{"columns":[{"name":"Goal","type":"string"},{"name":"Target","type":"string"},{"name":"Indicator","type":"string"},{"name":"SeriesCode","type":"string"},{"name":"SeriesDescription","type":"string"},{"name":"GeoAreaCode","type":"string"},{"name":"GeoAreaName","type":"string"},{"name":"TimePeriod","type":"string"},{"name":"Value","type":"string"},{"name":"Time_Detail","type":"string"},{"name":"TimeCoverage","type":"string"},{"name":"UpperBound","type":"string"},{"name":"LowerBound","type":"string"},{"name":"BasePeriod","type":"string"},{"name":"Source","type":"string"},{"name":"GeoInfoUrl","type":"string"},{"name":"FootNote","type":"string"},{"name":"[Nature]","type":"string"},{"name":"[Reporting Type]","type":"string"},{"name":"[Sex]","type":"string"},{"name":"[Substance use disorders]","type":"string"},{"name":"[Units]","type":"string"}],"n_rows":2031,"rows_kept":2031,"cut":false,"text_format":"parquet-jsonl-2026-10-02","bounds":{"document_bytes":16777216,"package_text_limit_bytes":33554432,"package_text_slack_bytes":1024,"rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096,"vector_min":64,"vector_head_fixed":16,"vector_head_variable":64,"kv_value_chars":1048576,"nesting_max":64,"binary_text":true},"cells_cut":0,"cells_bad_utf8":0,"cells_raw":0,"cells_binary":0,"cells_binary_text":0,"cells_vector":0,"n_row_groups":1,"reader":"pyarrow 23.0.1, python 3.13","created_by":"DuckDB version v1.2.2 (build 7c039464e4)","schema":{"fields":[{"name":"Goal","type":"string","nullable":true,"metadata":null,"children":null},{"name":"Target","type":"string","nullable":true,"metadata":null,"children":null},{"name":"Indicator","type":"string","nullable":true,"metadata":null,"children":null},{"name":"SeriesCode","type":"string","nullable":true,"metadata":null,"children":null},{"name":"SeriesDescription","type":"string","nullable":true,"metadata":null,"children":null},{"name":"GeoAreaCode","type":"string","nullable":true,"metadata":null,"children":null},{"name":"GeoAreaName","type":"string","nullable":true,"metadata":null,"children":null},{"name":"TimePeriod","type":"string","nullable":true,"metadata":null,"children":null},{"name":"Value","type":"string","nullable":true,"metadata":null,"children":null},{"name":"Time_Detail","type":"string","nullable":true,"metadata":null,"children":null},{"name":"TimeCoverage","type":"string","nullable":true,"metadata":null,"children":null},{"name":"UpperBound","type":"string","nullable":true,"metadata":null,"children":null},{"name":"LowerBound","type":"string","nullable":true,"metadata":null,"children":null},{"name":"BasePeriod","type":"string","nullable":true,"metadata":null,"children":null},{"name":"Source","type":"string","nullable":true,"metadata":null,"children":null},{"name":"GeoInfoUrl","type":"string","nullable":true,"metadata":null,"children":null},{"name":"FootNote","type":"string","nullable":true,"metadata":null,"children":null},{"name":"[Nature]","type":"string","nullable":true,"metadata":null,"children":null},{"name":"[Reporting Type]","type":"string","nullable":true,"metadata":null,"children":null},{"name":"[Sex]","type":"string","nullable":true,"metadata":null,"children":null},{"name":"[Substance use disorders]","type":"string","nullable":true,"metadata":null,"children":null},{"name":"[Units]","type":"string","nullable":true,"metadata":null,"children":null}],"parquet":"required group field_id=-1 duckdb_schema {\n  optional binary field_id=-1 Goal (String);\n  optional binary field_id=-1 Target (String);\n  optional binary field_id=-1 Indicator (String);\n  optional binary field_id=-1 SeriesCode (String);\n  optional binary field_id=-1 SeriesDescription (String);\n  optional binary field_id=-1 GeoAreaCode (String);\n  optional binary field_id=-1 GeoAreaName (String);\n  optional binary field_id=-1 TimePeriod (String);\n  optional binary field_id=-1 Value (String);\n  optional binary field_id=-1 Time_Detail (String);\n  optional binary field_id=-1 TimeCoverage (String);\n  optional binary field_id=-1 UpperBound (String);\n  optional binary field_id=-1 LowerBound (String);\n  optional binary field_id=-1 BasePeriod (String);\n  optional binary field_id=-1 Source (String);\n  optional binary field_id=-1 GeoInfoUrl (String);\n  optional binary field_id=-1 FootNote (String);\n  optional binary field_id=-1 [Nature] (String);\n  optional binary field_id=-1 [Reporting Type] (String);\n  optional binary field_id=-1 [Sex] (String);\n  optional binary field_id=-1 [Substance use disorders] (String);\n  optional binary field_id=-1 [Units] (String);\n}\n"},"kv_metadata":[]}
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","12","Algeria","2016","2.89","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","12","Algeria","2016","11.94","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","12","Algeria","2016","40.1","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","12","Algeria","2016","18.18","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","12","Algeria","2017","18.72","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","12","Algeria","2017","12.42","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","12","Algeria","2017","3.28","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","12","Algeria","2018","13.48","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","12","Algeria","2018","45.23","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","12","Algeria","2019","12.89","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","12","Algeria","2019","40.51","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","12","Algeria","2020","11.89","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","12","Algeria","2020","3.47","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","12","Algeria","2020","17.64","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","12","Algeria","2021","10.79","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","12","Algeria","2021","2.91","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","12","Algeria","2021","16.18","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","19","Americas","2015","13.0","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","19","Americas","2015","10.53","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","19","Americas","2015","14.84","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","19","Americas","2016","13.3","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","19","Americas","2016","15.23","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","19","Americas","2016","10.73","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","19","Americas","2017","13.7","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","19","Americas","2017","12.33","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","19","Americas","2017","14.65","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","19","Americas","2018","15.93","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","19","Americas","2018","11.00","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","19","Americas","2018","13.8","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","19","Americas","2019","12.9","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","19","Americas","2019","9.95","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","19","Americas","2019","15.05","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","19","Americas","2020","10.5","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","19","Americas","2020","12.47","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","19","Americas","2020","8.01","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","19","Americas","2021","10.4","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","19","Americas","2021","7.77","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","19","Americas","2021","12.40","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","19","Americas","2022","12.00","2022",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","19","Americas","2022","7.39","2022",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","19","Americas","2022","10.0","2022",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","19","Americas","2023","9.6","2023",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","19","Americas","2023","7.03","2023",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","19","Americas","2023","11.51","2023",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","20","Andorra","2015","14.94","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","20","Andorra","2015","13.24","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","20","Andorra","2015","17.94","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","20","Andorra","2015","17.4","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","20","Andorra","2015","16.71","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","20","Andorra","2016","21.78","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","20","Andorra","2016","19.51","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","20","Andorra","2016","22.66","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","20","Andorra","2016","22.3","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","20","Andorra","2017","2.37","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","20","Andorra","2017","10.85","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","20","Andorra","2017","14.47","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","20","Andorra","2017","1.74","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","20","Andorra","2017","1.11","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","20","Andorra","2017","32.22","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","20","Andorra","2017","26.73","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","20","Andorra","2017","0","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","20","Andorra","2017","23.85","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","20","Andorra","2017","26.26","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","20","Andorra","2018","29.41","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","20","Andorra","2018","18.6","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","20","Andorra","2018","3.29","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","20","Andorra","2019","2.16","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","20","Andorra","2019","29.31","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","20","Andorra","2019","40.68","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","20","Andorra","2019","26.72","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","20","Andorra","2021","1.64","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","20","Andorra","2021","1.05","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","20","Andorra","2021","17.91","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","20","Andorra","2021","27.17","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","20","Andorra","2021","23.76","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","20","Andorra","2021","13.64","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","20","Andorra","2021","16.03","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","20","Andorra","2021","26.23","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","24","Angola","2017","10.59","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","24","Angola","2018","1.24","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","24","Angola","2018","0.6","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","24","Angola","2018","3.26","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","24","Angola","2018","0.41","2018",null,null,null,null,"World Health Organization",null,null,"M","G","BOTHSEX","ALCOHOL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","24","Angola","2018","18.8","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","24","Angola","2018","11.68","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","24","Angola","2018","0.91","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","28","Antigua and Barbuda","2021","1.46","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","28","Antigua and Barbuda","2021","0","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","28","Antigua and Barbuda","2021","0","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","28","Antigua and Barbuda","2021","0","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","28","Antigua and Barbuda","2021","0","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","28","Antigua and Barbuda","2021","7.69","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","28","Antigua and Barbuda","2021","1.48","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","28","Antigua and Barbuda","2021","0","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","28","Antigua and Barbuda","2021","4.01","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","28","Antigua and Barbuda","2021","1.53","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","28","Antigua and Barbuda","2021","0","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","28","Antigua and Barbuda","2021","4.96","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","31","Azerbaijan","2016","11.33","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","1","World","2015","10.7","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","1","World","2015","5.70","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","1","World","2015","14.19","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","1","World","2016","5.62","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","1","World","2016","14.04","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","1","World","2016","10.6","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","1","World","2017","10.4","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","1","World","2017","13.38","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","1","World","2017","5.98","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","1","World","2018","5.55","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","1","World","2018","13.40","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","1","World","2018","10.2","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","1","World","2019","9.9","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","1","World","2019","13.14","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","1","World","2019","5.24","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","1","World","2020","4.40","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","1","World","2020","11.68","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","1","World","2020","8.6","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","1","World","2021","8.6","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","1","World","2021","11.70","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","1","World","2021","4.33","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","1","World","2022","11.51","2022",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","1","World","2022","4.20","2022",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","1","World","2022","8.4","2022",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","1","World","2023","8.1","2023",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","1","World","2023","4.02","2023",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","1","World","2023","11.12","2023",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","2","Africa","2015","2.8","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","2","Africa","2015","0.58","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","2","Africa","2015","4.32","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","2","Africa","2016","0.62","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","2","Africa","2016","2.8","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","2","Africa","2016","4.39","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","2","Africa","2017","4.38","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","2","Africa","2017","2.8","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","2","Africa","2017","0.63","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","2","Africa","2018","0.65","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","2","Africa","2018","2.9","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","2","Africa","2018","4.53","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","2","Africa","2019","4.42","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","2","Africa","2019","2.8","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","2","Africa","2019","0.60","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","2","Africa","2020","0.63","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","2","Africa","2020","2.9","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","2","Africa","2020","4.54","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","31","Azerbaijan","2017","11.92","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","31","Azerbaijan","2017","4.87","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","31","Azerbaijan","2018","6.44","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","31","Azerbaijan","2018","1.02","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","31","Azerbaijan","2018","43.52","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","31","Azerbaijan","2018","19.35","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","31","Azerbaijan","2018","10.72","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","31","Azerbaijan","2018","0.61","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","32","Argentina","2018","15.51","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/SDG Pre-Pub 2024",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","2","Africa","2021","4.43","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","2","Africa","2021","2.9","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","2","Africa","2021","0.66","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","2","Africa","2022","0.83","2022",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","2","Africa","2022","3.2","2022",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","2","Africa","2022","4.79","2022",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","2","Africa","2023","5.22","2023",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","2","Africa","2023","3.4","2023",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","2","Africa","2023","0.80","2023",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","4","Afghanistan","2014","14.84","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","4","Afghanistan","2015","16.77","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","4","Afghanistan","2015","27.73","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","8","Albania","2015","18.98","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","8","Albania","2017","0.36","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","8","Albania","2017","10.66","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","8","Albania","2017","10.54","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","8","Albania","2017","6.65","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","8","Albania","2018","1.74","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","8","Albania","2018","30.71","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","8","Albania","2018","49.1","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","8","Albania","2021","0.72","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","8","Albania","2021","0.06","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","8","Albania","2021","0","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","8","Albania","2021","10.43","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","8","Albania","2021","3.43","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","8","Albania","2021","15.31","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","8","Albania","2021","0.45","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","32","Argentina","2018","18.02","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/SDG Pre-Pub 2024",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","32","Argentina","2018","11.27","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/SDG Pre-Pub 2024",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","36","Australia","2017","17.97","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","36","Australia","2021","26.39","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","36","Australia","2021","19.68","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","36","Australia","2021","12.11","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","36","Australia","2021","3.18","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","40","Austria","2015","28.48","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","40","Austria","2015","20.28","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","8","Albania","2021","0.09","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","8","Albania","2021","2.75","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","8","Albania","2021","2.72","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","8","Albania","2021","2.59","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","8","Albania","2021","1.88","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","9","Oceania","2015","17.3","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","9","Oceania","2015","16.35","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","9","Oceania","2015","17.94","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","9","Oceania","2016","17.94","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","9","Oceania","2016","16.32","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","9","Oceania","2016","17.3","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","9","Oceania","2017","17.3","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","9","Oceania","2017","16.32","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","9","Oceania","2017","17.95","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","9","Oceania","2018","18.33","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","9","Oceania","2018","16.68","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","9","Oceania","2018","17.7","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","9","Oceania","2019","18.1","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","9","Oceania","2019","18.70","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","9","Oceania","2019","17.03","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","9","Oceania","2020","18.86","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","9","Oceania","2020","17.33","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","9","Oceania","2020","18.3","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","9","Oceania","2021","18.5","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","9","Oceania","2021","17.71","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","9","Oceania","2021","19.04","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","9","Oceania","2022","15.69","2022",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","9","Oceania","2022","14.55","2022",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","9","Oceania","2022","15.3","2022",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","9","Oceania","2023","15.6","2023",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","9","Oceania","2023","14.87","2023",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","9","Oceania","2023","16.01","2023",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","12","Algeria","2014","1.71","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","12","Algeria","2014","10.56","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","12","Algeria","2014","16.68","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","12","Algeria","2015","2.07","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","40","Austria","2015","32.32","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","40","Austria","2017","30.14","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","40","Austria","2017","35.8","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","40","Austria","2017","18.44","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","40","Austria","2018","38.39","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","40","Austria","2018","32.18","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","40","Austria","2018","19.66","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","40","Austria","2019","39.04","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","40","Austria","2019","20.69","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","40","Austria","2019","32.89","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","40","Austria","2020","33.01","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","40","Austria","2021","40.47","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","40","Austria","2021","34.05","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","40","Austria","2021","21.71","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","51","Armenia","2018","3.85","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","51","Armenia","2018","9.92","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","51","Armenia","2020","0.63","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","51","Armenia","2020","2.11","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","51","Armenia","2020","0.01","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","51","Armenia","2020","0.03","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","52","Barbados","2016","0.27","2016",null,null,null,null,"World Health Organization",null,null,"M","G","BOTHSEX","ALCOHOL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","56","Belgium","2015","18.27","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","56","Belgium","2015","35.87","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","56","Belgium","2015","29.43","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","56","Belgium","2017","18.02","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","56","Belgium","2017","36.45","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","56","Belgium","2017","29.66","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","56","Belgium","2018","35.49","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","56","Belgium","2018","17.43","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","56","Belgium","2018","28.83","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","56","Belgium","2018","1.17","2018",null,null,null,null,"World Health Organization",null,null,"M","G","BOTHSEX","ALCOHOL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","56","Belgium","2019","29.53","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","56","Belgium","2020","18.19","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","56","Belgium","2020","33.89","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","56","Belgium","2020","28.1","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","56","Belgium","2021","28.8","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","56","Belgium","2021","17.81","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","56","Belgium","2021","35.14","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","70","Bosnia and Herzegovina","2015","3.49","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","70","Bosnia and Herzegovina","2017","0.61","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","70","Bosnia and Herzegovina","2017","0.43","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","70","Bosnia and Herzegovina","2018","0.49","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","70","Bosnia and Herzegovina","2018","0.61","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","70","Bosnia and Herzegovina","2019","0.62","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","70","Bosnia and Herzegovina","2019","4.46","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","70","Bosnia and Herzegovina","2019","0.5","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","70","Bosnia and Herzegovina","2019","14.16","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2014","4.4","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2014","0.09","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2014","0.33","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2014","5.95","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2014","4.74","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2014","4.7","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2014","2.67","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2014","0.12","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2014","0.08","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2014","1.54","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2014","0.75","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2014","3.52","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2015","4.23","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2015","1.05","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2015","0.27","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2015","2.63","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2015","3.18","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2015","3.02","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2015","0.54","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2015","5.25","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2015","2.54","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2017","3.76","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2017","1.8","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2017","0.06","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2017","0.05","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2017","2.34","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2017","0.27","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2017","0.06","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2017","4.63","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2017","2.1","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2017","0.6","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2017","0.38","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2017","2.01","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2018","0.08","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2018","3.91","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2018","1.7","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2018","0.07","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2018","2.75","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2018","2.32","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2018","0.4","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2018","4.89","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2018","0.06","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2018","0.84","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2018","2.06","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","76","Brazil","2018","2.55","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","96","Brunei Darussalam","2014","4.87","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","96","Brunei Darussalam","2014","7.69","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","96","Brunei Darussalam","2014","0.72","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","96","Brunei Darussalam","2015","4.28","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","96","Brunei Darussalam","2015","6.41","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","96","Brunei Darussalam","2015","1.13","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","96","Brunei Darussalam","2016","3.35","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","96","Brunei Darussalam","2016","1.19","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","96","Brunei Darussalam","2016","2.48","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","96","Brunei Darussalam","2017","3.54","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","96","Brunei Darussalam","2017","0.77","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","96","Brunei Darussalam","2017","2.43","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","96","Brunei Darussalam","2018","1.08","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","96","Brunei Darussalam","2018","4.27","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","96","Brunei Darussalam","2018","3","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","96","Brunei Darussalam","2019","0.8","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","96","Brunei Darussalam","2019","3.49","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","96","Brunei Darussalam","2019","2.43","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","96","Brunei Darussalam","2020","1","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","96","Brunei Darussalam","2020","2.98","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","96","Brunei Darussalam","2020","4.26","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","96","Brunei Darussalam","2021","2.81","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","96","Brunei Darussalam","2021","3.95","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","96","Brunei Darussalam","2021","1.06","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","96","Brunei Darussalam","2021","7.94","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","96","Brunei Darussalam","2021","18.56","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","96","Brunei Darussalam","2021","23.89","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","100","Bulgaria","2015","4.88","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","100","Bulgaria","2015","17.51","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","100","Bulgaria","2015","3.42","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","100","Bulgaria","2015","69.72","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","100","Bulgaria","2017","54.24","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","100","Bulgaria","2017","2.99","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","100","Bulgaria","2017","8.19","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","100","Bulgaria","2017","16.04","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","100","Bulgaria","2018","20.97","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","100","Bulgaria","2018","17.2","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","100","Bulgaria","2019","16.56","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","100","Bulgaria","2020","15.55","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","12","Algeria","2015","10.05","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","12","Algeria","2015","15.56","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","100","Bulgaria","2021","15.46","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","104","Myanmar","2015","0.18","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","104","Myanmar","2015","3.25","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","104","Myanmar","2015","0.15","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","104","Myanmar","2015","35.15","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","104","Myanmar","2015","4.99","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","104","Myanmar","2016","42.4","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","104","Myanmar","2016","0.12","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","104","Myanmar","2016","0.69","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","104","Myanmar","2016","6.32","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","104","Myanmar","2016","4.08","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","104","Myanmar","2017","0.97","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","104","Myanmar","2017","0","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","104","Myanmar","2017","0.17","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","104","Myanmar","2017","76.72","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","104","Myanmar","2017","45.45","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","104","Myanmar","2017","1.73","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","104","Myanmar","2017","1.1","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","104","Myanmar","2017","4.44","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","104","Myanmar","2017","6.85","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","104","Myanmar","2018","5.22","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","104","Myanmar","2018","53.73","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","104","Myanmar","2018","2.89","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","104","Myanmar","2018","6.52","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","104","Myanmar","2019","0.76","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","104","Myanmar","2019","6.32","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","104","Myanmar","2019","66.69","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","104","Myanmar","2020","31.87","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","104","Myanmar","2020","5.41","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","104","Myanmar","2020","0.94","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","104","Myanmar","2020","3.36","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","104","Myanmar","2020","0.16","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","104","Myanmar","2021","84.62","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","104","Myanmar","2021","8.29","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","104","Myanmar","2021","0.94","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","112","Belarus","2016","19.77","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","112","Belarus","2021","10.13","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","112","Belarus","2021","6.37","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","112","Belarus","2021","38.54","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","112","Belarus","2021","27.55","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","112","Belarus","2021","23.82","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","112","Belarus","2021","4.54","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","112","Belarus","2021","35","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","112","Belarus","2021","1.71","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","112","Belarus","2021","10.78","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","116","Cambodia","2020","5.42","2020",null,null,null,null,"Institute for Health Metrics and Evaluation",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","124","Canada","2017","13.41","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/https://www.ccsa.ca/sites/default/files/2021-01/CCSA-National-value_Total-Indicators-2016-2018-data_any_drug-Report-2021-en.pdf",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","124","Canada","2017","12.75","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/https://www.ccsa.ca/sites/default/files/2021-01/CCSA-National-value_Total-Indicators-2016-2018-data_any_drug-Report-2021-en.pdf",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","124","Canada","2017","13.85","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","124","Canada","2018","13.33","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/https://www.ccsa.ca/sites/default/files/2021-01/CCSA-National-value_Total-Indicators-2016-2018-data_any_drug-Report-2021-en.pdf",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","124","Canada","2018","13.7","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","124","Canada","2018","12.77","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/https://www.ccsa.ca/sites/default/files/2021-01/CCSA-National-value_Total-Indicators-2016-2018-data_any_drug-Report-2021-en.pdf",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","132","Cabo Verde","2020","76.23","2020",null,null,null,null,"Institute for Health Metrics and Evaluation",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","140","Central African Republic","2017","7.53","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","140","Central African Republic","2017","1.75","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","142","Asia","2015","6.9","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","142","Asia","2015","2.26","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","142","Asia","2015","10.16","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","142","Asia","2016","10.01","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","142","Asia","2016","2.11","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","142","Asia","2016","6.7","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","142","Asia","2017","6.4","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","142","Asia","2017","1.98","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","142","Asia","2017","9.42","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","142","Asia","2018","1.86","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","142","Asia","2018","9.07","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","142","Asia","2018","6.1","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","142","Asia","2019","1.87","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","142","Asia","2019","6.1","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","142","Asia","2019","9.03","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","142","Asia","2020","7.56","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","142","Asia","2020","4.9","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","142","Asia","2020","1.30","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","142","Asia","2021","1.29","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","142","Asia","2021","4.9","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","142","Asia","2021","7.67","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","142","Asia","2022","1.29","2022",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","142","Asia","2022","7.64","2022",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","142","Asia","2022","4.9","2022",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","142","Asia","2023","1.25","2023",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","142","Asia","2023","4.8","2023",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","142","Asia","2023","7.50","2023",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","144","Sri Lanka","2014","1.4","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","144","Sri Lanka","2014","8.92","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","144","Sri Lanka","2015","7.25","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","144","Sri Lanka","2015","1.18","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","144","Sri Lanka","2016","0.07","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","144","Sri Lanka","2016","1.99","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","144","Sri Lanka","2016","3.34","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","144","Sri Lanka","2017","13.86","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","144","Sri Lanka","2017","0.1","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","144","Sri Lanka","2017","2.28","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","144","Sri Lanka","2017","23.9","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","144","Sri Lanka","2017","0.02","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","144","Sri Lanka","2017","3.87","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","144","Sri Lanka","2019","17","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","144","Sri Lanka","2020","1.37","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","144","Sri Lanka","2020","0.03","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","144","Sri Lanka","2020","2.32","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","144","Sri Lanka","2021","2.39","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","144","Sri Lanka","2021","0.01","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","144","Sri Lanka","2021","1.41","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","144","Sri Lanka","2023","2.14","2023",null,null,null,null,"SDG prepub/SDG prepub",null,null,"C","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","150","Europe","2015","27.8","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","150","Europe","2015","14.35","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","150","Europe","2015","35.18","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","150","Europe","2016","34.73","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","150","Europe","2016","14.14","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","150","Europe","2016","27.4","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","150","Europe","2017","26.7","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","150","Europe","2017","13.85","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","150","Europe","2017","33.84","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","150","Europe","2018","33.85","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","150","Europe","2018","14.15","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","150","Europe","2018","26.8","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","150","Europe","2019","14.02","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","150","Europe","2019","27.2","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","150","Europe","2019","34.51","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","150","Europe","2020","34.15","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","150","Europe","2020","26.9","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","150","Europe","2020","14.11","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","150","Europe","2021","27.3","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","150","Europe","2021","34.62","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","150","Europe","2021","14.23","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","150","Europe","2022","14.27","2022",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","150","Europe","2022","34.25","2022",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","150","Europe","2022","27.0","2022",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","150","Europe","2023","27.9","2023",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","150","Europe","2023","14.75","2023",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","150","Europe","2023","35.13","2023",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"E","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2014","28.25","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2014","6","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2014","0.09","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2014","0.09","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2014","6.77","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2014","20","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2014","0.09","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2014","25.44","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2014","0.2","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2014","4.62","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2014","0.39","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2014","0.28","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2015","23.62","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2015","6.4","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2015","0.11","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2015","4.96","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2015","7.2","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2015","0.2","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2015","0.11","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2015","0.15","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2015","30.15","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2015","27.93","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2015","0.09","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2015","0.1","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2016","6.17","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2016","6.8","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2016","20.94","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2016","0.08","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2016","30.57","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2016","5.04","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2016","0.31","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2016","0.08","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2016","0.08","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2016","0.42","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2016","0.22","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2016","27.31","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2017","0.43","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2017","0.27","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2017","0.32","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2017","12.61","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2017","42.69","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2017","10.65","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2017","0.27","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2017","37.62","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2017","0.64","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2017","0.35","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2017","7.06","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2017","27.67","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2018","10.65","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2018","0.92","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2018","0.38","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2018","7.46","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2018","36.53","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2018","12.38","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2018","0.62","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2018","0.19","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2018","0.26","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2018","0.23","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2019","0.27","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2019","26.88","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2019","11.48","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2019","0.18","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2019","0.3","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2019","0.25","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2019","0.6","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2019","10.01","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2019","36.23","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2019","7.28","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2019","33.11","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2019","1.03","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2020","20.25","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2020","0.56","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2020","0.31","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2020","7.56","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2020","0.52","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2020","8.53","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2020","5.79","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2020","22.83","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2020","0.8","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2020","0.41","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2020","24.12","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2020","0.19","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2021","0.42","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2021","1.71","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2021","1.17","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2021","0.96","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2021","8.84","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2021","25.05","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2021","24.01","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2021","0.4","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2021","8","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2021","0.64","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2021","6.45","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","152","Chile","2021","21.88","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","156","China","2014","7.32","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: the sum of the Compulsory isolated drug treatment + Community treatment  as reported by  China National Narcotic Committee + the number of participants in the Methadone Mentainace Programs as reported in The Decade-Long Chinese Methadone Maintenance Therapy Yields Large Population and Economic Benefits for Drug Users in Reducing Harm, HIV and HCV Disease Burden, Lei Zhang Xia Zou, Yong Xu , Nick Medland , Liwei Deng , Yin Liu , Shu Su  and Li Ling, frontiers in Public Health, 2019",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","156","China","2015","11.29","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: the sum of the Compulsory isolated drug treatment + Community treatment  as reported by  China National Narcotic Committee + the number of participants in the Methadone Mentainace Programs as reported in The Decade-Long Chinese Methadone Maintenance Therapy Yields Large Population and Economic Benefits for Drug Users in Reducing Harm, HIV and HCV Disease Burden, Lei Zhang Xia Zou, Yong Xu , Nick Medland , Liwei Deng , Yin Liu , Shu Su  and Li Ling, frontiers in Public Health, 2019",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","156","China","2015","4.48","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: the sum of the Compulsory isolated drug treatment + Community treatment  as reported by  China National Narcotic Committee + the number of participants in the Methadone Mentainace Programs as reported in The Decade-Long Chinese Methadone Maintenance Therapy Yields Large Population and Economic Benefits for Drug Users in Reducing Harm, HIV and HCV Disease Burden, Lei Zhang Xia Zou, Yong Xu , Nick Medland , Liwei Deng , Yin Liu , Shu Su  and Li Ling, frontiers in Public Health, 2019",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","156","China","2016","10.94","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: the sum of the Compulsory isolated drug treatment + Community treatment  as reported by  China National Narcotic Committee + the number of participants in the Methadone Mentainace Programs as reported in The Decade-Long Chinese Methadone Maintenance Therapy Yields Large Population and Economic Benefits for Drug Users in Reducing Harm, HIV and HCV Disease Burden, Lei Zhang Xia Zou, Yong Xu , Nick Medland , Liwei Deng , Yin Liu , Shu Su  and Li Ling, frontiers in Public Health, 2019",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","156","China","2017","9.88","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: the sum of the Compulsory isolated drug treatment + Community treatment  as reported by  China National Narcotic Committee + the number of participants in the Methadone Mentainace Programs as reported in The Decade-Long Chinese Methadone Maintenance Therapy Yields Large Population and Economic Benefits for Drug Users in Reducing Harm, HIV and HCV Disease Burden, Lei Zhang Xia Zou, Yong Xu , Nick Medland , Liwei Deng , Yin Liu , Shu Su  and Li Ling, frontiers in Public Health, 2019",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","156","China","2018","9.09","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: the sum of the Compulsory isolated drug treatment + Community treatment  as reported by  China National Narcotic Committee + the number of participants in the Methadone Mentainace Programs as reported in The Decade-Long Chinese Methadone Maintenance Therapy Yields Large Population and Economic Benefits for Drug Users in Reducing Harm, HIV and HCV Disease Burden, Lei Zhang Xia Zou, Yong Xu , Nick Medland , Liwei Deng , Yin Liu , Shu Su  and Li Ling, frontiers in Public Health, 2019",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","156","China","2019","9.16","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: the sum of the Compulsory isolated drug treatment + Community treatment  as reported by  China National Narcotic Committee + the number of participants in the Methadone Mentainace Programs as reported in The Decade-Long Chinese Methadone Maintenance Therapy Yields Large Population and Economic Benefits for Drug Users in Reducing Harm, HIV and HCV Disease Burden, Lei Zhang Xia Zou, Yong Xu , Nick Medland , Liwei Deng , Yin Liu , Shu Su  and Li Ling, frontiers in Public Health, 2019",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","156","China","2020","5.75","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: the sum of the Compulsory isolated drug treatment + Community treatment  as reported by  China National Narcotic Committee + the number of participants in the Methadone Mentainace Programs as reported in The Decade-Long Chinese Methadone Maintenance Therapy Yields Large Population and Economic Benefits for Drug Users in Reducing Harm, HIV and HCV Disease Burden, Lei Zhang Xia Zou, Yong Xu , Nick Medland , Liwei Deng , Yin Liu , Shu Su  and Li Ling, frontiers in Public Health, 2019",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","170","Colombia","2021","2.05","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","170","Colombia","2021","1.29","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","170","Colombia","2021","2.01","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","170","Colombia","2021","2.41","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","191","Croatia","2014","6.63","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","191","Croatia","2014","22.59","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","191","Croatia","2015","22.27","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","191","Croatia","2016","21.62","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","191","Croatia","2017","22.55","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","191","Croatia","2018","1.84","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","191","Croatia","2018","2.44","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","191","Croatia","2018","13.19","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","191","Croatia","2018","9.66","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","191","Croatia","2018","2.74","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","191","Croatia","2018","3.05","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","191","Croatia","2018","22.1","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","191","Croatia","2018","75.4","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","191","Croatia","2018","58.06","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","191","Croatia","2018","27.36","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","191","Croatia","2020","17.23","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","191","Croatia","2020","52.02","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","191","Croatia","2020","2.62","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","191","Croatia","2020","24.1","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","191","Croatia","2020","3.65","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","191","Croatia","2020","3.03","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","191","Croatia","2020","1.75","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","191","Croatia","2020","18.55","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","191","Croatia","2020","66.56","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","191","Croatia","2020","12.46","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","191","Croatia","2021","24.09","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","191","Croatia","2021","3.03","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","191","Croatia","2021","4.05","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","191","Croatia","2021","3.65","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","191","Croatia","2021","1.77","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","191","Croatia","2021","14.17","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","191","Croatia","2021","18.67","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","191","Croatia","2021","10.58","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","191","Croatia","2021","8.54","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","191","Croatia","2021","54.6","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","191","Croatia","2021","26.12","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","191","Croatia","2021","68.84","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2015","16.11","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2015","20.85","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2015","7.69","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2015","5.9","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2015","2.21","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2015","9.74","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2015","22.06","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2015","33.72","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2015","3.18","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2015","0.11","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2015","4.86","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2015","0.42","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2016","11.55","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2016","5.11","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2016","3.54","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2016","15.63","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2016","31.58","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2016","9.08","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2016","5.43","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2016","20.67","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2016","20.53","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2016","0.25","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2016","2.17","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2016","0.08","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2017","1.89","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2017","0.11","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2017","6.16","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2017","4.56","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2017","15.44","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2017","4.03","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2017","20.26","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2017","30.64","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2017","5.13","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2017","19.98","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2017","12.72","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2017","10.96","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2018","14.32","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2018","17.94","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2018","4.75","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2018","2.16","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2018","19.99","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2018","22.1","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2018","30.47","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2018","7.26","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2018","1.01","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2018","6.72","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2018","0.15","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2018","17.18","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2019","3.84","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2019","14","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2019","8.08","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2019","12.74","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2019","9.3","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2019","4.82","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2019","2.62","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2019","2.76","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2020","20.19","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2020","4.08","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2020","7.87","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2020","7.39","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2020","12.42","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2020","9.95","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2020","15.41","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2020","17.76","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2020","5.3","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2020","18.97","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2020","3.32","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2020","22.23","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2021","3.74","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2021","9.46","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2021","13.83","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2021","16.48","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2021","17.98","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2021","21.13","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2021","7.4","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2021","6.87","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2021","18.14","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2021","2.45","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2021","11.23","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","196","Cyprus","2021","4.86","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","203","Czechia","2015","37.23","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","203","Czechia","2015","35.38","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","203","Czechia","2015","32.08","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","203","Czechia","2017","44.24","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","203","Czechia","2017","34.1","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","203","Czechia","2017","40.62","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","203","Czechia","2018","45.11","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","203","Czechia","2018","4.02","2018",null,null,null,null,"World Health Organization",null,null,"M","G","BOTHSEX","ALCOHOL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","203","Czechia","2018","48.48","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","203","Czechia","2018","47.28","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","203","Czechia","2019","50.29","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","203","Czechia","2019","45.73","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","203","Czechia","2019","48.66","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","203","Czechia","2021","67.81","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","208","Denmark","2015","29.02","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","208","Denmark","2017","28.72","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","208","Denmark","2021","27.62","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","214","Dominican Republic","2014","1.63","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","214","Dominican Republic","2014","2.53","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","214","Dominican Republic","2015","3.43","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","214","Dominican Republic","2015","0.49","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","214","Dominican Republic","2015","5.14","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","214","Dominican Republic","2016","0.02","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","214","Dominican Republic","2016","0","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","214","Dominican Republic","2016","2.15","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","214","Dominican Republic","2016","3.4","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","214","Dominican Republic","2016","0.37","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","214","Dominican Republic","2016","4.12","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","214","Dominican Republic","2016","5.74","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","214","Dominican Republic","2016","1.26","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","214","Dominican Republic","2016","0.46","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","214","Dominican Republic","2016","0.02","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","218","Ecuador","2015","43.06","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","218","Ecuador","2015","32.38","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","218","Ecuador","2015","21.58","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","218","Ecuador","2015","0.52","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","222","El Salvador","2018","7.07","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","222","El Salvador","2018","4.73","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","222","El Salvador","2018","1.45","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","222","El Salvador","2018","3.48","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","222","El Salvador","2018","0.72","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","222","El Salvador","2018","0.37","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","222","El Salvador","2018","1.31","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","222","El Salvador","2018","10.26","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","222","El Salvador","2018","1.93","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","222","El Salvador","2018","0.4","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","222","El Salvador","2019","0.5","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","222","El Salvador","2019","4.12","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","222","El Salvador","2019","5.97","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","222","El Salvador","2019","0.91","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","222","El Salvador","2019","7.22","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","222","El Salvador","2019","2.61","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","222","El Salvador","2019","17.16","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","222","El Salvador","2019","1.37","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","222","El Salvador","2019","0.85","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","222","El Salvador","2019","0.44","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","222","El Salvador","2019","0.35","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","222","El Salvador","2019","10.64","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","233","Estonia","2015","5.8","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","233","Estonia","2017","8.01","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","233","Estonia","2018","8.11","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","233","Estonia","2018","6.34","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","233","Estonia","2018","7.58","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","233","Estonia","2019","8.53","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","233","Estonia","2019","6.71","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","233","Estonia","2019","7.99","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","233","Estonia","2020","8.38","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","233","Estonia","2020","6.19","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","233","Estonia","2020","9.31","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","233","Estonia","2021","5.7","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","233","Estonia","2021","8.79","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","233","Estonia","2021","7.89","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","250","France","2015","49.31","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","250","France","2017","19.23","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","250","France","2017","53.66","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","250","France","2017","40.11","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","250","France","2018","40.39","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","250","France","2019","40.61","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","250","France","2020","40.81","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","268","Georgia","2017","0.33","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","268","Georgia","2017","14.73","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","268","Georgia","2017","1.6","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","268","Georgia","2017","22.88","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","268","Georgia","2017","0","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","268","Georgia","2017","2.45","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","268","Georgia","2018","0.91","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","268","Georgia","2019","0.36","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","276","Germany","2015","46.12","2015",null,null,null,null,"SDG prepub/SDG prepub",null,"Figures for the number of people in treatment are based on a national extrapolation. The figures of DUD are rounded and are based on the treatment multiplier. Results should only be taken as rough approximations.","C","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","276","Germany","2015","46.22","2015",null,null,null,null,"SDG prepub 2024/SDG prepub 2024",null,"Figures for the number of people in treatment are based on a national extrapolation. With respect to opioid use, they may be underreported. The figures of DUD are rounded and are based on the treatment multiplier. Results should only be taken as rough approximations. Based on the results of a combined method study estimating the number of people with opioid addiction in Germany in 2016, it is assumed that with respect to the opioids group there is an underreporting of approx. 11%. submissions.","C","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","276","Germany","2015","46.21","2015",null,null,null,null,"SDG prepub 2024/SDG prepub 2024",null,"Figures for the number of people in treatment are based on a national extrapolation. With respect to opioid use, they may be underreported. The figures of DUD are rounded and are based on the treatment multiplier. Results should only be taken as rough approximations. Based on the results of a combined method study estimating the number of people with opioid addiction in Germany in 2016, it is assumed that with respect to the opioids group there is an underreporting of approx. 11%. submissions.","C","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","276","Germany","2016","46.94","2016",null,null,null,null,"SDG prepub/SDG prepub",null,"Figures for the number of people in treatment are based on a national extrapolation. The figures of DUD are rounded and are based on the treatment multiplier. Results should only be taken as rough approximations.","C","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","276","Germany","2016","46.37","2016",null,null,null,null,"SDG prepub 2024/SDG prepub 2024",null,"Figures for the number of people in treatment are based on a national extrapolation. With respect to opioid use, they may be underreported. The figures of DUD are rounded and are based on the treatment multiplier. Results should only be taken as rough approximations. Based on the results of a combined method study estimating the number of people with opioid addiction in Germany in 2016, it is assumed that with respect to the opioids group there is an underreporting of approx. 11%. submissions.","C","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","276","Germany","2016","46.15","2016",null,null,null,null,"SDG prepub 2024/SDG prepub 2024",null,"Figures for the number of people in treatment are based on a national extrapolation. With respect to opioid use, they may be underreported. The figures of DUD are rounded and are based on the treatment multiplier. Results should only be taken as rough approximations. Based on the results of a combined method study estimating the number of people with opioid addiction in Germany in 2016, it is assumed that with respect to the opioids group there is an underreporting of approx. 11%. submissions.","C","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","276","Germany","2017","46.21","2017",null,null,null,null,"SDG prepub 2024/SDG prepub 2024",null,"Figures for the number of people in treatment are based on a national extrapolation. With respect to opioid use, they may be underreported. The figures of DUD are rounded and are based on the treatment multiplier. Results should only be taken as rough approximations. Based on the results of a combined method study estimating the number of people with opioid addiction in Germany in 2016, it is assumed that with respect to the opioids group there is an underreporting of approx. 11%. submissions.","C","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","276","Germany","2017","45.99","2017",null,null,null,null,"SDG prepub/SDG prepub",null,"Figures for the number of people in treatment are based on a national extrapolation. The figures of DUD are rounded and are based on the treatment multiplier. Results should only be taken as rough approximations.","C","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","276","Germany","2017","46.16","2017",null,null,null,null,"SDG prepub 2024/SDG prepub 2024",null,"Figures for the number of people in treatment are based on a national extrapolation. With respect to opioid use, they may be underreported. The figures of DUD are rounded and are based on the treatment multiplier. Results should only be taken as rough approximations. Based on the results of a combined method study estimating the number of people with opioid addiction in Germany in 2016, it is assumed that with respect to the opioids group there is an underreporting of approx. 11%. submissions.","C","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","276","Germany","2018","46.31","2018",null,null,null,null,"SDG prepub 2024/SDG prepub 2024",null,"Figures for the number of people in treatment are based on a national extrapolation. With respect to opioid use, they may be underreported. The figures of DUD are rounded and are based on the treatment multiplier. Results should only be taken as rough approximations. Based on the results of a combined method study estimating the number of people with opioid addiction in Germany in 2016, it is assumed that with respect to the opioids group there is an underreporting of approx. 11%. submissions.","C","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","276","Germany","2018","46.24","2018",null,null,null,null,"SDG prepub/SDG prepub",null,"Figures for the number of people in treatment are based on a national extrapolation. The figures of DUD are rounded and are based on the treatment multiplier. Results should only be taken as rough approximations.","C","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","276","Germany","2018","46.47","2018",null,null,null,null,"SDG prepub 2024/SDG prepub 2024",null,"Figures for the number of people in treatment are based on a national extrapolation. With respect to opioid use, they may be underreported. The figures of DUD are rounded and are based on the treatment multiplier. Results should only be taken as rough approximations. Based on the results of a combined method study estimating the number of people with opioid addiction in Germany in 2016, it is assumed that with respect to the opioids group there is an underreporting of approx. 11%. submissions.","C","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","276","Germany","2019","46.08","2019",null,null,null,null,"SDG prepub 2024/SDG prepub 2024",null,"Figures for the number of people in treatment are based on a national extrapolation. With respect to opioid use, they may be underreported. The figures of DUD are rounded and are based on the treatment multiplier. Results should only be taken as rough approximations. Based on the results of a combined method study estimating the number of people with opioid addiction in Germany in 2016, it is assumed that with respect to the opioids group there is an underreporting of approx. 11%. submissions.","C","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","276","Germany","2019","46.24","2019",null,null,null,null,"SDG prepub 2025/SDG prepub 2025",null,"Figures for the number of people in treatment are based on a national extrapolation. The figures of DUD are rounded and are based on the treatment multiplier. Results should only be taken as rough approximations.","C","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","276","Germany","2019","46.45","2019",null,null,null,null,"SDG prepub 2024/SDG prepub 2024",null,"Figures for the number of people in treatment are based on a national extrapolation. The figures of DUD are rounded and are based on the treatment multiplier. Results should only be taken as rough approximations.","C","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","276","Germany","2019","46.18","2019",null,null,null,null,"SDG prepub 2024/SDG prepub 2024",null,"Figures for the number of people in treatment are based on a national extrapolation. With respect to opioid use, they may be underreported. The figures of DUD are rounded and are based on the treatment multiplier. Results should only be taken as rough approximations. Based on the results of a combined method study estimating the number of people with opioid addiction in Germany in 2016, it is assumed that with respect to the opioids group there is an underreporting of approx. 11%. submissions.","C","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","276","Germany","2020","46.22","2020",null,null,null,null,"SDG prepub 2024/SDG prepub 2025",null,"Figures for the number of people in treatment are based on a national extrapolation. With respect to opioid use, they may be underreported. The figures of DUD are rounded and are based on the treatment multiplier. Results should only be taken as rough approximations. Based on the results of a combined method study estimating the number of people with opioid addiction in Germany in 2016, it is assumed that with respect to the opioids group there is an underreporting of approx. 11%. submissions.","C","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","276","Germany","2020","46.34","2020",null,null,null,null,"SDG prepub 2024/SDG prepub 2024",null,"Figures for the number of people in treatment are based on a national extrapolation. With respect to opioid use, they may be underreported. The figures of DUD are rounded and are based on the treatment multiplier. Results should only be taken as rough approximations. Based on the results of a combined method study estimating the number of people with opioid addiction in Germany in 2016, it is assumed that with respect to the opioids group there is an underreporting of approx. 11%. submissions.","C","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","276","Germany","2020","46.27","2020",null,null,null,null,"SDG prepub 2025/SDG prepub 2025",null,"Figures for the number of people in treatment are based on a national extrapolation. The figures of DUD are rounded and are based on the treatment multiplier. Results should only be taken as rough approximations.","C","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","276","Germany","2020","45.69","2020",null,null,null,null,"SDG prepub 2024/SDG prepub 2024",null,"Figures for the number of people in treatment are based on a national extrapolation. The figures of DUD are rounded and are based on the treatment multiplier. Results should only be taken as rough approximations.","C","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","276","Germany","2021","46.11","2021",null,null,null,null,"SDG prepub 2024/SDG prepub 2024",null,"Figures for the number of people in treatment are based on a national extrapolation. The figures of DUD are rounded and are based on the treatment multiplier. Results should only be taken as rough approximations.","C","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","276","Germany","2021","46.27","2021",null,null,null,null,"SDG prepub 2024/SDG prepub 2024",null,"Figures for the number of people in treatment are based on a national extrapolation. With respect to opioid use, they may be underreported. The figures of DUD are rounded and are based on the treatment multiplier. Results should only be taken as rough approximations. Based on the results of a combined method study estimating the number of people with opioid addiction in Germany in 2016, it is assumed that with respect to the opioids group there is an underreporting of approx. 11%. submissions.","C","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","276","Germany","2021","46.07","2021",null,null,null,null,"SDG prepub 2024/SDG prepub 2024",null,"Figures for the number of people in treatment are based on a national extrapolation. The figures of DUD are rounded and are based on the treatment multiplier. Results should only be taken as rough approximations.","C","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","276","Germany","2021","46.45","2021",null,null,null,null,"SDG prepub 2024/SDG prepub 2024",null,"Figures for the number of people in treatment are based on a national extrapolation. With respect to opioid use, they may be underreported. The figures of DUD are rounded and are based on the treatment multiplier. Results should only be taken as rough approximations. Based on the results of a combined method study estimating the number of people with opioid addiction in Germany in 2016, it is assumed that with respect to the opioids group there is an underreporting of approx. 11%. submissions.","C","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","276","Germany","2022","46.35","2022",null,null,null,null,"SDG prepub 2024/SDG prepub2024",null,"Figures for the number of people in treatment are based on a national extrapolation. With respect to opioid use, they may be underreported. The figures of DUD are rounded and are based on the treatment multiplier. Results should only be taken as rough approximations. Based on the results of a combined method study estimating the number of people with opioid addiction in Germany in 2016, it is assumed that with respect to the opioids group there is an underreporting of approx. 11%. submissions.","C","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","276","Germany","2022","46.86","2022",null,null,null,null,"SDG prepub 2024/SDG prepub 2024",null,"Figures for the number of people in treatment are based on a national extrapolation. The figures of DUD are rounded and are based on the treatment multiplier. Results should only be taken as rough approximations.","C","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","276","Germany","2022","46.46","2022",null,null,null,null,"SDG prepub 2024/SDG prepub 2024",null,"Figures for the number of people in treatment are based on a national extrapolation. With respect to opioid use, they may be underreported. The figures of DUD are rounded and are based on the treatment multiplier. Results should only be taken as rough approximations. Based on the results of a combined method study estimating the number of people with opioid addiction in Germany in 2016, it is assumed that with respect to the opioids group there is an underreporting of approx. 11%. submissions.","C","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","276","Germany","2022","46.7","2022",null,null,null,null,"SDG prepub 2025/SDG prepub 2025",null,"Figures for the number of people in treatment are based on a national extrapolation. The figures of DUD are rounded and are based on the treatment multiplier. Results should only be taken as rough approximations.","C","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","276","Germany","2023","46.61","2023",null,null,null,null,"SDG prepub 2025/SDG prepub 2025",null,"Figures for the number of people in treatment are based on a national extrapolation. The figures of DUD are rounded and are based on the treatment multiplier. Results should only be taken as rough approximations.","C","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","276","Germany","2023","46.22","2023",null,null,null,null,"SDG prepub 2025/SDG prepub 2025",null,"Figures for the number of people in treatment are based on a national extrapolation. The figures of DUD are rounded and are based on the treatment multiplier. Results should only be taken as rough approximations.","C","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","276","Germany","2023","46.36","2023",null,null,null,null,"SDG prepub 2025/SDG prepub 2025",null,"Figures for the number of people in treatment are based on a national extrapolation. With respect to opioid use, they may be underreported. The figures of DUD are rounded and are based on the treatment multiplier. Results should only be taken as rough approximations. Based on the results of a combined method study estimating the number of people with opioid addiction in Germany in 2016, it is assumed that with respect to the opioids group there is an underreporting of approx. 11%. submissions.","C","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","276","Germany","2023","46.38","2023",null,null,null,null,"SDG prepub 2025/SDG prepub 2025",null,"Figures for the number of people in treatment are based on a national extrapolation. With respect to opioid use, they may be underreported. The figures of DUD are rounded and are based on the treatment multiplier. Results should only be taken as rough approximations. Based on the results of a combined method study estimating the number of people with opioid addiction in Germany in 2016, it is assumed that with respect to the opioids group there is an underreporting of approx. 11%. submissions.","C","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","300","Greece","2014","22.19","2014",null,null,null,null,"SDG prepub/SDG prepub",null,null,"C","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","300","Greece","2022","65.3","2022",null,null,null,null,"SDG prepub/SDG prepub",null,null,"C","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","300","Greece","2023","75.93","2023",null,null,null,null,"SDG prepub/SDG prepub",null,null,"C","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","308","Grenada","2018","3.46","2018",null,null,null,null,"World Health Organization",null,null,"M","G","BOTHSEX","ALCOHOL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","320","Guatemala","2016","0.63","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","320","Guatemala","2016","2.4","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","320","Guatemala","2016","0.22","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","320","Guatemala","2016","1.05","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","320","Guatemala","2016","0.38","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","320","Guatemala","2016","1.81","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","320","Guatemala","2017","0.13","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","320","Guatemala","2017","1.57","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","320","Guatemala","2017","1.49","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","320","Guatemala","2017","1.67","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","320","Guatemala","2017","0.34","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","320","Guatemala","2017","0.22","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","320","Guatemala","2018","0.6","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","320","Guatemala","2018","0.97","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","320","Guatemala","2018","0.8","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","320","Guatemala","2019","0.99","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","320","Guatemala","2019","1.48","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","320","Guatemala","2019","1.47","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","320","Guatemala","2019","0.6","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","320","Guatemala","2019","0.03","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","320","Guatemala","2019","0.41","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","320","Guatemala","2020","0.57","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","320","Guatemala","2020","0.6","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","320","Guatemala","2020","0.79","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","320","Guatemala","2020","0.97","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","320","Guatemala","2020","0.15","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","320","Guatemala","2020","0.33","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","320","Guatemala","2021","0.02","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","320","Guatemala","2021","0.51","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","320","Guatemala","2021","0.81","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","320","Guatemala","2021","0.27","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","320","Guatemala","2021","0.68","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","320","Guatemala","2021","0.75","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","320","Guatemala","2021","0.87","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","324","Guinea","2021","3.3","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","348","Hungary","2015","2.54","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","348","Hungary","2015","10.31","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","348","Hungary","2015","7.43","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","348","Hungary","2017","3.07","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","348","Hungary","2017","8.61","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","348","Hungary","2017","11.83","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","348","Hungary","2018","2.8","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","348","Hungary","2018","8.59","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","348","Hungary","2018","11.92","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","348","Hungary","2019","11.51","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","348","Hungary","2019","3.21","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","348","Hungary","2019","8.48","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","348","Hungary","2020","8.03","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","348","Hungary","2021","8.16","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","352","Iceland","2017","17.86","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","352","Iceland","2017","9.86","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","352","Iceland","2017","23.95","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","352","Iceland","2017","32.99","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","352","Iceland","2017","60.78","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","352","Iceland","2017","39.35","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","352","Iceland","2017","27.4","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","352","Iceland","2018","4.19","2018",null,null,null,null,"World Health Organization",null,null,"M","G","BOTHSEX","ALCOHOL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","356","India","2019","5.01","2019",null,null,null,null,"UNODC Survey 2019/UNODC Survey 2019",null,null,"C","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","360","Indonesia","2017","0.32","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","360","Indonesia","2017","3.48","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","360","Indonesia","2017","2.07","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","360","Indonesia","2018","1.99","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","360","Indonesia","2018","0.67","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","360","Indonesia","2019","0.1","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","360","Indonesia","2019","0.71","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","360","Indonesia","2019","1.34","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","360","Indonesia","2019","0.71","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","360","Indonesia","2019","0.21","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","360","Indonesia","2019","1.1","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","360","Indonesia","2020","1.74","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","368","Iraq","2021","0.32","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/National (entire country)",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","368","Iraq","2021","0.05","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/National (entire country)",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","368","Iraq","2021","0.34","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/National (entire country)",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","368","Iraq","2021","2.34","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/National (entire country)",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","368","Iraq","2021","0.02","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/National (entire country)",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","368","Iraq","2021","0.1","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/National (entire country)",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","372","Ireland","2015","17.82","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","372","Ireland","2016","18.43","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","372","Ireland","2018","18.11","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","372","Ireland","2019","17.92","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","372","Ireland","2020","19.27","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","372","Ireland","2021","19.68","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","376","Israel","2014","20.97","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","376","Israel","2015","19.1","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","376","Israel","2016","16.02","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","376","Israel","2016","13.93","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","376","Israel","2016","12.62","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","376","Israel","2016","6.63","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","376","Israel","2016","21.55","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","376","Israel","2016","1.79","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2014","0.15","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2014","25.41","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2014","35.14","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2014","9.44","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2015","0.27","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2015","0.21","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2015","41.52","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2015","29.95","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2015","10.88","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2015","11.34","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2015","48.3","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2015","72.72","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2015","0.12","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2016","40.69","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2016","29.41","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2016","0.29","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2016","10.72","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2016","0.23","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2016","73.15","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2016","11.52","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2016","48.48","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2016","0.14","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2017","12.11","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2017","0.12","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2017","10.21","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2017","76.19","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2017","0.22","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2017","0.28","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2017","9.98","2017",null,null,null,null,"World Health Organization",null,null,"M","G","BOTHSEX","ALCOHOL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2017","27.49","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2017","37.85","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2017","50.33","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2018","47.13","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2018","0.21","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2018","28.93","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2018","71.01","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2018","0.14","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2018","0.25","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2018","11.04","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2018","39.6","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2018","12.29","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2019","50.03","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2019","0.26","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2019","75.3","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2019","30.14","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2019","13.44","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2019","41.25","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2019","0.2","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2019","11.47","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2019","0.11","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2020","37.02","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2020","10.51","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2020","27.11","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2020","75.68","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2020","50.54","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2020","0.09","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2020","0.19","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2020","14.19","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2020","0.24","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2021","51.82","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2021","0.16","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2021","14.94","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2021","10.42","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2021","37.22","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2021","0.07","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2021","0.21","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2021","27.13","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","380","Italy","2021","77.54","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","384","Côte d'Ivoire","2021","0.83","2021",null,null,null,null,"Institute for Health Metrics and Evaluation",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2016","1.05","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2016","0.03","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2016","4.98","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2016","0.5","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2016","3.23","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2016","4.42","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2016","0.04","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2016","0","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2016","3.31","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2017","4.9","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2017","4.52","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2017","0.49","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2017","3.28","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2017","3.28","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2017","0.17","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2017","0.96","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2018","0.67","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2018","3.66","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2018","1.06","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2018","4.51","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2018","0.75","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2018","3.07","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2018","0.47","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2018","5.02","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2018","0.51","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2019","3.24","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2019","0.88","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2019","0.69","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2019","0.97","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2019","0.37","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2019","4.07","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2019","2.22","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2019","2.98","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2019","1.09","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2020","1.96","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2020","1.46","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2020","0","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2020","0.73","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2021","2.31","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2021","1.9","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2021","0.77","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","398","Kazakhstan","2021","0","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","400","Jordan","2015","0.08","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","400","Jordan","2019","0.51","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","400","Jordan","2019","0.3","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","400","Jordan","2019","7.19","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","400","Jordan","2019","4.26","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","400","Jordan","2019","13.18","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","410","Republic of Korea","2016","1.17","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","410","Republic of Korea","2016","0.02","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","410","Republic of Korea","2017","0","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","410","Republic of Korea","2017","0.01","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","410","Republic of Korea","2017","1.14","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","410","Republic of Korea","2017","0.24","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","418","Lao People's Democratic Republic","2019","5.95","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","418","Lao People's Democratic Republic","2019","0.68","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","418","Lao People's Democratic Republic","2019","10.6","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","418","Lao People's Democratic Republic","2019","16.65","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","418","Lao People's Democratic Republic","2020","4.15","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2014","9.01","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2014","1.78","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2014","6.55","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2014","1.57","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2014","16.53","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2014","6.11","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2014","1.82","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2014","9.56","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2014","9.37","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2015","6.23","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2015","1.55","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2015","3.5","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2015","0.63","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2015","0.22","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2015","0.45","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2015","2.15","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2015","5.68","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2015","6.6","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2015","3.71","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2016","3.43","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2016","6.91","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2016","0.37","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2016","4","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2016","0.59","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2016","2.43","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2016","1.36","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2016","1.79","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2016","8.55","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2016","5.77","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2017","10.86","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2017","1.74","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2017","0.94","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2017","2.04","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2017","7.37","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2017","10.58","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2017","6.38","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2017","9.36","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2017","11.91","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2017","6.8","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2018","0.46","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2018","5.73","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2018","0.24","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2018","6.93","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2018","2.44","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2018","1.88","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2018","0.45","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2018","4.06","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2018","3.51","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2018","3.73","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2019","1.47","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2020","1.52","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2020","1.8","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2020","1.02","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2020","1.07","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2020","2.53","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2020","0.31","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2020","0.08","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2020","0.09","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2020","2.07","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2020","3.89","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2021","0.38","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2021","0.75","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2021","8.22","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2021","0.9","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2021","0.5","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2021","0.17","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2021","3.43","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","422","Lebanon","2021","5.07","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","428","Latvia","2023","20.73","2023",null,null,null,null,"SDG prepub 2025/SDG prepub 2025",null,"DUD - 2017 estimate (latest available). Partially ‘circular definition’ - number of people with DUD is an estimate where treatment multiplier method used.","C","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","428","Latvia","2023","9.18","2023",null,null,null,null,"SDG prepub 2025/SDG prepub 2025",null,"DUD 2017 estimate (latest available).  Partially ‘circular definition’ - number of people with DUD is an estimate where treatment multiplier method used.","C","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2014","0","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2014","4.95","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2014","7.27","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2014","29.61","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2014","28.42","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2014","18.19","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2014","0.91","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2014","0.71","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2014","45.29","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2014","0.11","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2014","26.35","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2014","50.88","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2015","0.11","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2015","4.73","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2015","1.31","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2015","1.03","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2015","2.61","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2015","24.99","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2015","0","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2015","27.79","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2015","17.74","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2015","6.88","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2015","4.57","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2015","4.1","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2016","22.9","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2016","23.2","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2016","0.56","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2016","0.12","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2016","34.97","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2016","16.92","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2016","6.58","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2016","38.51","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2016","25.15","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2016","0","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2016","4.57","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2016","0.71","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2017","0.64","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2017","27.11","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2017","13.17","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2017","16.46","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2017","4.86","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2017","0","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2017","0.82","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2017","3.4","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2017","19.03","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2017","0.09","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2017","24.71","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2017","17.46","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2018","8.4","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2018","9.34","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2018","0.52","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2018","0.41","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2018","0","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2018","6.18","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2018","5.07","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2018","1.6","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2018","0.05","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2018","6.83","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2018","2.27","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2018","4.36","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2019","2.11","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/SDG prepub",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2019","14.93","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/SDG prepub",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2019","20.02","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/SDG prepub",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2019","10.55","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/SDG prepub",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2019","6.27","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/SDG prepub",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2019","34.38","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/SDG prepub",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2019","2.99","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/SDG prepub",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2019","9.75","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/SDG prepub",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2019","9.52","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/SDG prepub",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2020","19.43","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/SDG prepub",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2020","3.02","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/SDG prepub",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2020","34.44","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/SDG prepub",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2020","3.49","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/SDG prepub",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2020","14.11","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/SDG prepub",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2020","9.06","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/SDG prepub",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2020","8.86","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/SDG prepub",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2020","9.78","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/SDG prepub",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2020","5.24","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/SDG prepub",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2021","3.29","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/SDG prepub",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2021","40.59","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/SDG prepub",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2021","10.59","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/SDG prepub",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2021","17.25","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/SDG prepub",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2021","3.99","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/SDG prepub",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2021","9.75","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/SDG prepub",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2021","3.84","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/SDG prepub",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2021","23.39","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/SDG prepub",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","440","Lithuania","2021","9.94","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/SDG prepub",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","442","Luxembourg","2017","42.4","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","442","Luxembourg","2018","20.09","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","442","Luxembourg","2018","33.74","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","442","Luxembourg","2018","28.65","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","442","Luxembourg","2019","41.03","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","442","Luxembourg","2020","32.76","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","442","Luxembourg","2020","17.7","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","442","Luxembourg","2020","41.72","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","442","Luxembourg","2021","37.09","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","442","Luxembourg","2021","81.8","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","442","Luxembourg","2021","65.17","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","458","Malaysia","2021","6.01","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","458","Malaysia","2021","82.22","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","458","Malaysia","2021","53.93","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2015","0.05","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Subnational",null,"Subnational","M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2015","1.15","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2015","1.34","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Subnational",null,"Subnational","M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2015","3.76","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2015","21.94","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Data revised by national authorities in response to the Pre-Publication of Sustainable Development Goals indicators (SDG-PrePub)",null,"Subnational","M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2015","0.37","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Subnational",null,"Subnational","M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2015","1.67","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Subnational",null,"Subnational","M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2015","6.81","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Subnational",null,"Subnational","M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2015","0.68","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Subnational",null,"Subnational","M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2015","0.25","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2016","4.71","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/National",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2016","2.41","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2016","7.2","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/National",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2016","7.08","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/National",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2016","19.55","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2016","0.23","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/National",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2016","4.89","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2016","38.18","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/National",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2016","21.76","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Data revised by national authorities in response to the Pre-Publication of Sustainable Development Goals indicators (SDG-PrePub)",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2016","1.34","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/National",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2017","8.07","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/National",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2017","1.53","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/National",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2017","7.08","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/National",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2017","14.3","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Data revised by national authorities in response to the Pre-Publication of Sustainable Development Goals indicators (SDG-PrePub)",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2017","23.37","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2017","2.46","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2017","44.72","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/National",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2017","0.31","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/National",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2017","6.23","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/National",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2017","5.49","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2018","66.5","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/National",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2018","0.34","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/National",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2018","9.57","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/National",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2018","6.39","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2018","33.99","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2018","9.57","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/National",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2018","21.5","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Data revised by national authorities in response to the Pre-Publication of Sustainable Development Goals indicators (SDG-PrePub)",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2018","7.74","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/National",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2018","3.26","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2018","1.52","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/National",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2019","23.88","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Data revised by national authorities in response to the Pre-Publication of Sustainable Development Goals indicators (SDG-PrePub)",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2019","68.81","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2019","21","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/National / Centros de tratamiento ambulatorios y residenciales",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2019","1.41","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/National / Centros de tratamiento ambulatorios y residenciales",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2019","16.29","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/National / Centros de tratamiento ambulatorios y residenciales",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2019","10.4","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2019","0.14","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/National / Centros de tratamiento ambulatorios y residenciales",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","484","Mexico","2019","6.73","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","496","Mongolia","2018","0.37","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","496","Mongolia","2018","3.18","2018",null,null,null,null,"World Health Organization",null,null,"M","G","BOTHSEX","ALCOHOL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","496","Mongolia","2018","0.2","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","498","Republic of Moldova","2018","2.96","2018",null,null,null,null,"World Health Organization",null,null,"M","G","BOTHSEX","ALCOHOL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","498","Republic of Moldova","2019","0","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","498","Republic of Moldova","2019","0.22","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","498","Republic of Moldova","2019","0.71","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","498","Republic of Moldova","2019","37.67","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","498","Republic of Moldova","2019","20.44","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","498","Republic of Moldova","2019","19.93","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","498","Republic of Moldova","2019","12.27","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","498","Republic of Moldova","2019","0.73","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","498","Republic of Moldova","2019","0.45","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","499","Montenegro","2015","22.93","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","499","Montenegro","2015","33.52","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","499","Montenegro","2015","4.95","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","499","Montenegro","2016","0","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","499","Montenegro","2016","25.43","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","499","Montenegro","2016","36.34","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","499","Montenegro","2016","6.89","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","499","Montenegro","2016","3.77","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","499","Montenegro","2016","2.29","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","499","Montenegro","2017","1.15","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","499","Montenegro","2017","0","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","499","Montenegro","2017","2.38","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","499","Montenegro","2017","12.42","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","499","Montenegro","2017","45.56","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","499","Montenegro","2017","1.9","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","499","Montenegro","2017","65.08","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","499","Montenegro","2019","0.5","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","499","Montenegro","2019","0.33","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","499","Montenegro","2019","10.61","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","499","Montenegro","2019","0","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","499","Montenegro","2019","0.96","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","499","Montenegro","2019","15.51","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","499","Montenegro","2019","0.01","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","499","Montenegro","2019","0.59","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","499","Montenegro","2019","2.29","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","499","Montenegro","2020","1.51","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","499","Montenegro","2020","21.7","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","499","Montenegro","2020","8.8","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","499","Montenegro","2020","15.86","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","499","Montenegro","2020","5.97","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","499","Montenegro","2020","13.45","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","499","Montenegro","2021","1.93","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","499","Montenegro","2021","1.93","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","499","Montenegro","2021","0","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","499","Montenegro","2021","1.18","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","499","Montenegro","2021","7.65","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","499","Montenegro","2021","0","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","499","Montenegro","2021","11.04","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","504","Morocco","2017","6.98","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","504","Morocco","2017","0.8","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","504","Morocco","2017","4.32","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","504","Morocco","2018","10.32","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","504","Morocco","2018","7.08","2018",null,null,null,null,"World Health Organization",null,null,"M","G","BOTHSEX","ALCOHOL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","504","Morocco","2018","6.41","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","504","Morocco","2018","1.19","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","504","Morocco","2019","6.52","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","504","Morocco","2019","10.6","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","504","Morocco","2019","2.53","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","504","Morocco","2019","1.07","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","504","Morocco","2019","10.07","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","504","Morocco","2020","6.97","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","504","Morocco","2020","0.44","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","504","Morocco","2020","20.38","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","504","Morocco","2020","2.82","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","504","Morocco","2020","32.94","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","504","Morocco","2020","3.27","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","504","Morocco","2020","12.87","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","504","Morocco","2020","14.33","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","504","Morocco","2021","16.43","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","504","Morocco","2021","17.09","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","504","Morocco","2021","11.07","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","504","Morocco","2021","3.84","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","504","Morocco","2021","1.56","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","512","Oman","2017","2.79","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","512","Oman","2017","5.31","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","512","Oman","2017","2.08","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","512","Oman","2017","0.06","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","512","Oman","2017","0.12","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","512","Oman","2017","3.14","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","512","Oman","2018","0.18","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","512","Oman","2018","3.03","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","512","Oman","2018","4.5","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","512","Oman","2019","1.62","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","512","Oman","2019","2.5","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","512","Oman","2019","0.29","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","512","Oman","2019","0.87","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","528","Netherlands (Kingdom of the)","2014","35.43","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","528","Netherlands (Kingdom of the)","2014","28.77","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","528","Netherlands (Kingdom of the)","2014","24.24","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","528","Netherlands (Kingdom of the)","2014","20.19","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","528","Netherlands (Kingdom of the)","2014","8.04","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","528","Netherlands (Kingdom of the)","2014","74.3","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","528","Netherlands (Kingdom of the)","2014","60.93","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","528","Netherlands (Kingdom of the)","2014","14.51","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","528","Netherlands (Kingdom of the)","2014","6.76","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","528","Netherlands (Kingdom of the)","2014","4.5","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","528","Netherlands (Kingdom of the)","2015","13.82","2015",null,null,null,null,"World Health Organization",null,null,"M","G","BOTHSEX","ALCOHOL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","528","Netherlands (Kingdom of the)","2018","49.97","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","528","Netherlands (Kingdom of the)","2018","64.03","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","528","Netherlands (Kingdom of the)","2018","25.8","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","528","Netherlands (Kingdom of the)","2018","22.86","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","528","Netherlands (Kingdom of the)","2018","11.85","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","528","Netherlands (Kingdom of the)","2018","20.13","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","528","Netherlands (Kingdom of the)","2018","6.94","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","528","Netherlands (Kingdom of the)","2018","28.73","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","558","Nicaragua","2014","0.75","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","558","Nicaragua","2014","2.42","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","558","Nicaragua","2014","0.95","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","558","Nicaragua","2014","3.65","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","558","Nicaragua","2017","0.57","2017",null,null,null,null,"World Health Organization",null,null,"M","G","BOTHSEX","ALCOHOL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","558","Nicaragua","2019","23.33","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","558","Nicaragua","2019","28.85","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","558","Nicaragua","2019","9.7","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","558","Nicaragua","2020","7.33","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","558","Nicaragua","2020","1.58","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","558","Nicaragua","2021","6.8","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","558","Nicaragua","2021","4.09","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","558","Nicaragua","2021","0.4","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","562","Niger","2021","6.01","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","562","Niger","2021","4.07","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","562","Niger","2021","0.37","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","566","Nigeria","2018","1.11","2018",null,null,null,null,"UNODC survey 2019/UNODC estimate, Nigeria survey",null,null,"C","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2014","31.79","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2014","25.87","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2014","3.33","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2014","1.38","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2014","27.05","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2014","23.49","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2014","32.19","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2014","29.62","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2014","20.39","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2014","3.94","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2014","27.3","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2014","22.06","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2015","10.11","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2015","2.25","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2015","10.08","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2015","8.26","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2015","11.14","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2015","0.86","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2015","4.16","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2015","1.91","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2015","9.86","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2015","9.94","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2015","3.06","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2015","3.7","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2017","9.72","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2017","8.92","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2017","8.48","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2017","4.16","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2017","2.32","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2017","1.88","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2017","7.74","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2017","3.59","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2017","10.89","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2017","2.46","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2017","2.83","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2017","9.1","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2018","31.1","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2018","31.68","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2018","5.18","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2018","20.79","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2018","23.77","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2018","23.01","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2018","38.31","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2018","19.58","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2018","32.55","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2018","28.68","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2019","20.85","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2019","6.67","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2019","7.66","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2019","21.34","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2019","31.81","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2019","31.18","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2019","36.09","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2019","22.96","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2019","3.61","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2019","22.56","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2020","7.36","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2020","30.38","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2020","24.17","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2020","23.42","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2020","8.47","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2020","20.81","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2020","21.81","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2020","32.54","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2020","20.4","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2020","34.13","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2020","3.99","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2020","39.65","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2021","8.32","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2021","22.65","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2021","29.99","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2021","20.6","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2021","20.51","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2021","33.89","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2021","9.51","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2021","23.64","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2021","4.78","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2021","38.6","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2021","20.82","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","578","Norway","2021","31.53","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","586","Pakistan","2013","0.75","2013",null,null,null,null,"UNODC survey/UNODC survey",null,null,"C","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","591","Panama","2018","2.14","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","591","Panama","2018","0.5","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","591","Panama","2018","0.94","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","591","Panama","2018","1.7","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","600","Paraguay","2020","39.05","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","600","Paraguay","2020","30.31","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","600","Paraguay","2020","17.15","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","604","Peru","2016","9.57","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","604","Peru","2020","3.27","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","604","Peru","2020","17.61","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","604","Peru","2020","6.62","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","604","Peru","2020","7.93","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","604","Peru","2020","0.19","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","604","Peru","2020","0.15","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","604","Peru","2020","6.61","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","604","Peru","2020","0.18","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","604","Peru","2020","0.38","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","604","Peru","2020","13.09","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","604","Peru","2020","0.16","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","604","Peru","2020","0.26","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","604","Peru","2021","0.86","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","604","Peru","2021","9.96","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","604","Peru","2021","2.18","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","604","Peru","2021","2.83","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","604","Peru","2021","21.58","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","604","Peru","2021","0.78","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","604","Peru","2021","12.51","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","604","Peru","2021","0.99","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","604","Peru","2021","1.8","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","604","Peru","2021","6.32","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","604","Peru","2021","13.71","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","604","Peru","2021","24.7","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","608","Philippines","2014","1.17","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","608","Philippines","2014","0.76","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","608","Philippines","2014","0.15","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","608","Philippines","2015","0.92","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","608","Philippines","2015","0.16","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","608","Philippines","2015","1.43","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","608","Philippines","2016","1.58","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","608","Philippines","2016","1.02","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","608","Philippines","2016","0.18","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","608","Philippines","2017","1.01","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","608","Philippines","2017","0.67","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","608","Philippines","2017","0.15","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","608","Philippines","2017","0.97","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","608","Philippines","2019","1.26","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","608","Philippines","2019","0.22","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","608","Philippines","2019","0.95","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","608","Philippines","2019","0.85","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","616","Poland","2021","2.81","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","616","Poland","2021","5.37","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","616","Poland","2021","27.46","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","616","Poland","2021","39.91","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","616","Poland","2021","95.91","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","616","Poland","2021","74.16","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","616","Poland","2021","14.96","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","616","Poland","2021","4.53","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","616","Poland","2021","64.03","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","616","Poland","2021","55.56","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","616","Poland","2021","12.46","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","616","Poland","2021","7.49","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","620","Portugal","2014","54","2014",null,null,null,null,"SDG prepub/SDG prepub 2025",null,null,"C","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","620","Portugal","2015","50.81","2015",null,null,null,null,"SDG prepub_2024/SDG prepub 2025",null,null,"C","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","620","Portugal","2015","2.6","2015",null,null,null,null,"SDG_prepub 2024/SDG prepub 2025",null,null,"C","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","620","Portugal","2016","49.89","2016",null,null,null,null,"SDG prepub_2024/SDG prepub 2025",null,null,"C","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","620","Portugal","2016","2.75","2016",null,null,null,null,"SDG prepub/SDG prepub 2025",null,null,"C","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","620","Portugal","2017","3.03","2017",null,null,null,null,"SDG prepub_2024/SDG prepub 2025",null,null,"C","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","620","Portugal","2017","47.99","2017",null,null,null,null,"SDG prepub_2024/SDG prepub 2025",null,null,"C","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","620","Portugal","2018","3.42","2018",null,null,null,null,"SDG prepub_2024/SDG prepub 2025",null,null,"C","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","620","Portugal","2018","53.28","2018",null,null,null,null,"SDG prepub_2024/SDG prepub 2025",null,null,"C","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","620","Portugal","2019","3.74","2019",null,null,null,null,"SDG prepub_2024/SDG prepub 2025",null,null,"C","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","620","Portugal","2019","51.76","2019",null,null,null,null,"SDG prepub_2024/SDG prepub 2025",null,null,"C","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","620","Portugal","2020","49.96","2020",null,null,null,null,"SDG prepub_2024/SDG prepub 2025",null,null,"C","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","620","Portugal","2020","3.66","2020",null,null,null,null,"SDG prepub/SDG prepub 2025",null,null,"C","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","620","Portugal","2021","51.41","2021",null,null,null,null,"SDG prepub_2024/SDG prepub 2025",null,null,"C","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","620","Portugal","2021","4.09","2021",null,null,null,null,"SDG prepub/SDG prepub 2025",null,null,"C","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","620","Portugal","2022","51.21","2022",null,null,null,null,"SDG prepub/SDG prepub_2025",null,null,"C","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","620","Portugal","2022","57.92","2022",null,null,null,null,"SDG prepub/SDG prepub 2025",null,null,"C","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","620","Portugal","2022","59.48","2022",null,null,null,null,"SDG prepub/SDG prepub_2024",null,null,"C","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","620","Portugal","2022","4.4","2022",null,null,null,null,"SDG prepub/SDG prepub 2025",null,null,"C","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","620","Portugal","2023","4.85","2023",null,null,null,null,"SDG prepub/SDG prepub",null,null,"C","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","620","Portugal","2023","51.06","2023",null,null,null,null,"SDG prepub/SDG prepub_2025",null,null,"C","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","620","Portugal","2023","57.46","2023",null,null,null,null,"SDG prepub/SDG prepub 2025",null,null,"C","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","620","Portugal","2023","58.96","2023",null,null,null,null,"SDG prepub/SDG prepub 2025",null,null,"C","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2014","0.1","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2014","1.89","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2014","5.06","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2014","4.47","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2014","7.9","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2014","0.09","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2014","0.07","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2014","0.3","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2015","0.07","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2015","2.02","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2015","4.56","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2015","5.62","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2015","0.01","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2015","0.28","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2015","0.18","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2015","7.54","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2016","0.17","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2016","0.55","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2016","1.83","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2016","3.82","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2016","0.25","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2016","0.33","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2016","6.77","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2016","6.23","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2017","2.11","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2017","3.78","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2017","0.37","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2017","0.4","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2017","7.2","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2017","7.54","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2017","1.01","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2017","0.09","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2020","7.79","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2020","9.2","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2020","2.34","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2021","1.45","2021",null,null,null,null,"Institute for Health Metrics and Evaluation",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2021","5.73","2021",null,null,null,null,"Institute for Health Metrics and Evaluation",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2021","6.1","2021",null,null,null,null,"Institute for Health Metrics and Evaluation",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2021","4.47","2021",null,null,null,null,"Institute for Health Metrics and Evaluation",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2021","1.02","2021",null,null,null,null,"Institute for Health Metrics and Evaluation",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2021","1.5","2021",null,null,null,null,"Institute for Health Metrics and Evaluation",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2021","1.2","2021",null,null,null,null,"Institute for Health Metrics and Evaluation",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2021","1.64","2021",null,null,null,null,"Institute for Health Metrics and Evaluation",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2021","3.03","2021",null,null,null,null,"Institute for Health Metrics and Evaluation",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2021","8.67","2021",null,null,null,null,"Institute for Health Metrics and Evaluation",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2021","0.33","2021",null,null,null,null,"Institute for Health Metrics and Evaluation",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","642","Romania","2021","0.76","2021",null,null,null,null,"Institute for Health Metrics and Evaluation",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","643","Russian Federation","2016","4.67","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","643","Russian Federation","2016","29.48","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","643","Russian Federation","2016","11.74","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","643","Russian Federation","2016","0.1","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","643","Russian Federation","2016","26.04","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","643","Russian Federation","2017","28.41","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","643","Russian Federation","2017","5.66","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","643","Russian Federation","2017","23.9","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","643","Russian Federation","2017","0.1","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","643","Russian Federation","2018","0.1","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","643","Russian Federation","2018","27.15","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","643","Russian Federation","2018","6.29","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","643","Russian Federation","2018","21.42","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","643","Russian Federation","2019","6.9","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","643","Russian Federation","2019","0.12","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","643","Russian Federation","2019","26.4","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","643","Russian Federation","2019","35.5","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","643","Russian Federation","2019","9.78","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","643","Russian Federation","2019","19.44","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","643","Russian Federation","2020","25.52","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","643","Russian Federation","2020","17.76","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","643","Russian Federation","2020","0.11","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","643","Russian Federation","2020","7.3","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","643","Russian Federation","2021","17.37","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","643","Russian Federation","2021","26.42","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","643","Russian Federation","2021","10","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","643","Russian Federation","2021","0.08","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","643","Russian Federation","2021","8.33","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","643","Russian Federation","2021","10.4","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","643","Russian Federation","2021","4.98","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","643","Russian Federation","2021","0.06","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","682","Saudi Arabia","2014","28.09","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","682","Saudi Arabia","2014","1.21","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","682","Saudi Arabia","2014","4.48","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","682","Saudi Arabia","2015","0.03","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","682","Saudi Arabia","2015","0.8","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","682","Saudi Arabia","2015","27.11","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","682","Saudi Arabia","2015","4.46","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","682","Saudi Arabia","2016","0.02","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","682","Saudi Arabia","2016","4.77","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","682","Saudi Arabia","2016","1.16","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","682","Saudi Arabia","2016","30.61","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","682","Saudi Arabia","2017","0.96","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","682","Saudi Arabia","2017","0.01","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","682","Saudi Arabia","2017","35.47","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","682","Saudi Arabia","2018","3.18","2018",null,null,null,null,"World Health Organization",null,null,"M","G","BOTHSEX","ALCOHOL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","682","Saudi Arabia","2019","0.23","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","682","Saudi Arabia","2019","37.68","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","682","Saudi Arabia","2019","5.62","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","682","Saudi Arabia","2020","4.6","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","682","Saudi Arabia","2020","30.86","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","682","Saudi Arabia","2020","0.14","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","682","Saudi Arabia","2020","0","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","682","Saudi Arabia","2021","0.11","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","682","Saudi Arabia","2021","24.67","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","688","Serbia","2015","10.76","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","688","Serbia","2018","18.03","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","688","Serbia","2018","6.04","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","688","Serbia","2018","0.48","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2014","0","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2014","0","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2014","0","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2014","10.35","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2014","4.91","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2014","1.73","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2014","8.44","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2014","5.63","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2014","8.76","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2015","3.21","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2015","5.53","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2015","12.42","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2015","8.42","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2015","2.4","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2015","1.28","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2015","11.06","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2015","1.04","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2015","3.14","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2016","12.64","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2016","15.14","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2016","0","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2016","0.68","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2016","3.7","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2016","2.54","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2016","3.53","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2016","7.9","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2016","1.18","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2016","0","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2016","0","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2016","2.08","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2017","2.39","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2017","8.07","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2017","0.64","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2017","12.25","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2017","3.31","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2017","14.54","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2017","2.03","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2017","1.17","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2017","3.67","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2018","2.37","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2018","2.69","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2018","1.35","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2018","1.35","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2018","16.25","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2018","13.9","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2018","9.68","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2018","0.49","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2018","3.7","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2019","19.05","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2019","23","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2019","13.64","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2019","6.43","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2019","0.02","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2019","2.14","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2019","0.01","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2019","1.92","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2019","12.09","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2019","0","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2019","7.22","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2019","4.58","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2020","7.23","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2020","5.09","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2020","2.3","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2021","4.56","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2021","1.94","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","702","Singapore","2021","6.59","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2015","16.63","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2015","0.7","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2015","7.78","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2015","10.28","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2015","22.4","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2015","7.3","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2015","14.01","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2015","0.54","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2015","0.33","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2015","10.19","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2015","3.43","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2015","4.94","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2016","1.04","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2016","0.47","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2016","9.68","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2016","8.1","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2016","4.82","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2016","9.5","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2016","15.02","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2016","1.48","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2016","12.2","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2016","18.2","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2016","23.44","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2016","20.15","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2017","1.27","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2017","7.08","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2017","0.44","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2017","18.18","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2017","11.97","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2017","22.68","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2017","4.56","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2017","13.4","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2017","0.91","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2017","5.29","2017",null,null,null,null,"World Health Organization",null,null,"M","G","BOTHSEX","ALCOHOL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2017","9.26","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2017","8.99","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2017","17.49","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2018","14.45","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2018","8.71","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2018","0.84","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2018","4.3","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2018","1.22","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2018","24.33","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2018","7.65","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2018","12.09","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2018","0.34","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2018","9.24","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2018","18.44","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2018","19.68","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2019","0.41","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2019","10.19","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2019","14.11","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2019","18.87","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2019","2.05","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2019","20.93","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2019","7.98","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2019","1.34","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2019","12.99","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2019","10.53","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2019","27.21","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2019","5.35","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2020","1.76","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2020","0.42","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2020","9.54","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2020","6.89","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2020","9.19","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2020","11.75","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2020","4.76","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2020","24.8","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2020","15.63","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2020","2.82","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2020","22.37","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2020","19.02","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2021","9.24","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2021","11.97","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2021","0.96","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2021","27.04","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2021","0.5","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2021","9.3","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2021","4.76","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2021","11.93","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2021","1.32","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2021","15.99","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2021","20.31","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","703","Slovakia","2021","6.79","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","710","South Africa","2015","4.99","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","710","South Africa","2015","6.52","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","710","South Africa","2015","2.32","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","710","South Africa","2017","3.38","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","710","South Africa","2017","4.1","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","710","South Africa","2017","2.23","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","710","South Africa","2017","0.85","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","710","South Africa","2017","2.42","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","710","South Africa","2017","0.53","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","710","South Africa","2017","6.28","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","710","South Africa","2017","1.03","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","710","South Africa","2017","1.29","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","710","South Africa","2017","4.88","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","710","South Africa","2017","4.28","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","710","South Africa","2017","9.59","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","710","South Africa","2018","5.76","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","710","South Africa","2018","4.54","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","710","South Africa","2018","2.38","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","710","South Africa","2020","1.41","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","710","South Africa","2020","3.4","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","710","South Africa","2020","4.45","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","710","South Africa","2020","3.97","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","710","South Africa","2020","0.83","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","710","South Africa","2020","11.98","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","710","South Africa","2020","5.35","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","710","South Africa","2020","1.56","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","710","South Africa","2020","1.47","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","710","South Africa","2020","1.07","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","710","South Africa","2020","5.94","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","710","South Africa","2020","0.38","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","724","Spain","2015","57.06","2015",null,null,null,null,"OEDA/PNSD Report",null,null,"C","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","724","Spain","2015","76.84","2015",null,null,null,null,"OEDA/PNSD Report",null,null,"C","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","724","Spain","2016","57.96","2016",null,null,null,null,"OEDA/PNSD Report",null,null,"C","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","724","Spain","2016","81.13","2016",null,null,null,null,"OEDA/PNSD Report",null,null,"C","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","724","Spain","2017","50.52","2017",null,null,null,null,"OEDA/PNSD Report",null,null,"C","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","724","Spain","2017","84.07","2017",null,null,null,null,"OEDA/PNSD Report",null,null,"C","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","724","Spain","2018","83.59","2018",null,null,null,null,"OEDA/PNSD Report",null,null,"C","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","724","Spain","2018","53.06","2018",null,null,null,null,"OEDA/PNSD Report",null,null,"C","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","724","Spain","2018","65.73","2018",null,null,null,null,"OEDA/PNSD Report",null,null,"C","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","724","Spain","2018","51.44","2018",null,null,null,null,"OEDA/PNSD Report",null,null,"C","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","724","Spain","2019","83.39","2019",null,null,null,null,"OEDA/PNSD Report",null,null,"C","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","724","Spain","2019","54.12","2019",null,null,null,null,"OEDA/PNSD Report",null,null,"C","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","724","Spain","2020","46.89","2020",null,null,null,null,"OEDA/PNSD Report",null,null,"C","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","724","Spain","2020","79.74","2020",null,null,null,null,"OEDA/PNSD Report",null,null,"C","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","724","Spain","2021","49.4","2021",null,null,null,null,"OEDA/PNSD Report",null,null,"C","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","724","Spain","2021","86.29","2021",null,null,null,null,"OEDA/PNSD Report",null,null,"C","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","724","Spain","2022","47.04","2022",null,null,null,null,"OEDA/PNSD Report",null,null,"C","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","724","Spain","2022","44.66","2022",null,null,null,null,"OEDA/PNSD Report",null,null,"C","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","724","Spain","2022","95.7","2022",null,null,null,null,"OEDA/PNSD Report",null,null,"C","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","724","Spain","2022","46.7","2022",null,null,null,null,"OEDA/PNSD Report",null,null,"C","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","752","Sweden","2015","53.68","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","752","Sweden","2015","48.67","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","752","Sweden","2015","46.43","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","752","Sweden","2017","43.43","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","752","Sweden","2017","45.5","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","752","Sweden","2017","50.12","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","752","Sweden","2018","40.07","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","752","Sweden","2018","42.79","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","752","Sweden","2018","38.86","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","752","Sweden","2019","47.69","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","752","Sweden","2019","44.68","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","752","Sweden","2019","43.34","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","752","Sweden","2020","46.01","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","752","Sweden","2020","41.58","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","752","Sweden","2020","42.95","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","752","Sweden","2021","37.43","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","752","Sweden","2021","40.68","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","752","Sweden","2021","35.97","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","762","Tajikistan","2014","1.45","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","762","Tajikistan","2014","4.21","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","762","Tajikistan","2015","2.22","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","762","Tajikistan","2015","0.04","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","762","Tajikistan","2015","3.67","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","762","Tajikistan","2015","1.31","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","762","Tajikistan","2016","1.12","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","762","Tajikistan","2016","3.37","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","762","Tajikistan","2018","1.27","2018",null,null,null,null,"World Health Organization",null,null,"M","G","BOTHSEX","ALCOHOL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","762","Tajikistan","2018","11.92","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","762","Tajikistan","2018","35.59","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","762","Tajikistan","2020","1.77","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","762","Tajikistan","2020","1.04","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","762","Tajikistan","2020","0.01","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","768","Togo","2020","3.17","2020",null,null,null,null,"Institute for Health Metrics and Evaluation",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","768","Togo","2021","18.14","2021",null,null,null,null,"Institute for Health Metrics and Evaluation",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","784","United Arab Emirates","2020","1.18","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","784","United Arab Emirates","2020","0.48","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","784","United Arab Emirates","2020","1.27","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","792","Türkiye","2018","1.41","2018",null,null,null,null,"World Health Organization",null,null,"M","G","BOTHSEX","ALCOHOL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","804","Ukraine","2014","0.29","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","804","Ukraine","2014","11.59","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","804","Ukraine","2014","10.48","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","804","Ukraine","2014","17.45","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","804","Ukraine","2014","0.33","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","804","Ukraine","2014","0.19","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","804","Ukraine","2014","15.59","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","804","Ukraine","2014","5.53","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","804","Ukraine","2014","14.41","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","804","Ukraine","2015","14.75","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","804","Ukraine","2015","5.05","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","804","Ukraine","2015","19.22","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","804","Ukraine","2017","16.2","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","804","Ukraine","2017","0.28","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","804","Ukraine","2017","17.65","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","804","Ukraine","2017","8.03","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","804","Ukraine","2017","0.33","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","804","Ukraine","2017","21.99","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","804","Ukraine","2017","1.73","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","804","Ukraine","2017","0.69","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","804","Ukraine","2017","0.15","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","804","Ukraine","2017","28.02","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","804","Ukraine","2017","2.31","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","804","Ukraine","2017","24.93","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","804","Ukraine","2018","10.61","2018",null,null,null,null,"World Health Organization",null,null,"M","G","BOTHSEX","ALCOHOL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","804","Ukraine","2019","2.44","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","804","Ukraine","2019","24.1","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","804","Ukraine","2019","18.14","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","804","Ukraine","2020","24.61","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","804","Ukraine","2020","1.97","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","804","Ukraine","2020","18.77","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","804","Ukraine","2021","19.85","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","804","Ukraine","2021","26.13","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","804","Ukraine","2021","1.99","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","818","Egypt","2020","0.18","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","818","Egypt","2020","0.17","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","818","Egypt","2020","0.15","2020",null,null,null,null,"Institute for Health Metrics and Evaluation",null,null,"M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","818","Egypt","2020","0.11","2020",null,null,null,null,"Institute for Health Metrics and Evaluation",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","818","Egypt","2020","0.01","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","818","Egypt","2020","4.48","2020",null,null,null,null,"Institute for Health Metrics and Evaluation",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","818","Egypt","2020","8.06","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","818","Egypt","2020","0.23","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","818","Egypt","2020","0.02","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","826","United Kingdom of Great Britain and Northern Ireland","2015","23.7","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","826","United Kingdom of Great Britain and Northern Ireland","2015","20.2","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","826","United Kingdom of Great Britain and Northern Ireland","2015","14.15","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","826","United Kingdom of Great Britain and Northern Ireland","2017","13.55","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","826","United Kingdom of Great Britain and Northern Ireland","2017","18.96","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","826","United Kingdom of Great Britain and Northern Ireland","2017","22.14","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","826","United Kingdom of Great Britain and Northern Ireland","2018","21.77","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","826","United Kingdom of Great Britain and Northern Ireland","2018","13.56","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","826","United Kingdom of Great Britain and Northern Ireland","2018","18.72","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","826","United Kingdom of Great Britain and Northern Ireland","2019","19.06","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/EUDA",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","826","United Kingdom of Great Britain and Northern Ireland","2019","11.8","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","826","United Kingdom of Great Britain and Northern Ireland","2019","23.35","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/UNODC estimate: Estimate based on the total number of treated as reported from EUDA and the Female / Male percentage of treated as reported in the ARQ",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","840","United States of America","2014","12.19","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/TEDS",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","840","United States of America","2015","15.16","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/TEDS",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","840","United States of America","2015","12.58","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/TEDS",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","840","United States of America","2015","17.12","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/TEDS",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","840","United States of America","2016","15.58","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/TEDS",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","840","United States of America","2016","12.88","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/TEDS",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","840","United States of America","2016","18.54","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/TEDS",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","840","United States of America","2017","18.69","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/TEDS",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","840","United States of America","2017","13.52","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/TEDS",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","840","United States of America","2017","16.38","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/TEDS",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","840","United States of America","2018","13.1","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/TEDS",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","840","United States of America","2018","15.97","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/TEDS",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","840","United States of America","2018","18.35","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/TEDS",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","840","United States of America","2019","14.34","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/TEDS",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","840","United States of America","2019","11.48","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/TEDS",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","840","United States of America","2019","16.72","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/TEDS",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","840","United States of America","2020","12.87","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/TEDS",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","840","United States of America","2020","10.97","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/TEDS",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","840","United States of America","2020","8.74","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/TEDS",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","840","United States of America","2021","10.79","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/TEDS",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","840","United States of America","2021","12.56","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/TEDS",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","854","Burkina Faso","2017","1.91","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","854","Burkina Faso","2017","0.03","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","854","Burkina Faso","2017","1.1","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","854","Burkina Faso","2017","0.55","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","854","Burkina Faso","2021","0.57","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,"Subnational","M","G","BOTHSEX","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","854","Burkina Faso","2021","3.74","2021",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","COCAINE","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2014","2.86","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2014","0.41","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2014","3.5","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2014","7.37","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2014","0.22","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2014","1.75","2014",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2015","2.3","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2015","1.39","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2015","4.58","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2015","2.15","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2015","0.16","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2015","0.22","2015",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2016","0.03","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2016","2.04","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2016","4.61","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2016","2.11","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2016","1.25","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2016","0.07","2016",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2017","1.81","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2017","0.09","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2017","1.24","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2017","2.08","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2017","0.03","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2017","4.11","2017",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2018","2.27","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2018","0.17","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2018","1.38","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2018","3.01","2018",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2019","0.48","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2019","0.94","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2019","0","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2019","0.1","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2019","1.56","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2019","1.1","2019",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2020","0.1","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2020","0.01","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2020","1.1","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2020","0.49","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2020","0.02","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","OPIOIDS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2020","1.07","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2020","0","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","FEMALE","ATS","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2020","1.78","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","MALE","DRUG_TOTAL","PERCENT"]
["3","3.5","3.5.1","SH_SUD_TREAT","Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)","860","Uzbekistan","2020","0","2020",null,null,null,null,"Institute for Health Metrics and Evaluation/Annual Report Questionnaire",null,null,"M","G","BOTHSEX","ATS","PERCENT"]